E-K

Scott Ernst, MD. FRCPC.

Scott Ernst, MD. FRCPC.

Professor, Department of Oncology, Schulich School of Medicine & Dentistry, Western University. Medical Oncologist, Verspeeten Family Cancer Centre. London Health Sciences Centre.

Research Interests / Specializations: Clinical care; Translational research; Prostate, Kidney and Urothelial Cancer, Cutaneous Malignancies, National Melanoma Registry. Founder, Canadian Melanoma Network. Co-founder, Global Melanoma Network.
Aaron Fenster, PhD. O.ONT. FCAHS. FCCPM. FCOMP. FSPIE. FIEEE. FAAPM. FIOMP.

Aaron Fenster, PhD. O.ONT. FCAHS. FCCPM. FCOMP. FSPIE. FIEEE. FAAPM. FIOMP.

*Order of Canada. Professor, Departments of Biomedical Engineering, Oncology, Medical Imaging, and Medical Biophysics, Schulich School of Medicine & Dentistry, Western University. Chair, Division of Imaging Sciences, Department of Medical Imaging, Schulich School of Medicine & Dentistry, Western University. Scientist, Imagine Research Laboratories, Robarts Research Institute. Co-Program Director, OICR Imaging Program, Chief Executive Officer and Chief Scientific Officer, Centre for Imaging Technology Commercialization. Scientist, Lawson Research Institute, St. Joseph's Health Care London.

Research Interests / Specializations: Image guided prostate cancer therapy, carotid atherosclerosis, MRI, 3D carotid ultrasound imaging.
Peter Ferguson, PhD.

Peter Ferguson, PhD.

Emeritus Adjunct Professor , Department of Oncology, Schulich School of Medicine & Dentistry, Western University. Associate Scientist, London Health Sciences Research Institute. Research Associate, Cancer Research Laboratory Program

Research Interests / Specializations: Anticancer Drug Development - antisense technology, small molecule inhibitors of DNA repair; tumour treatment methodologies - combination therapy, synergistic sensitization to anticancer drugs; tumour cell biology.
Ricardo Fernandes, MD.

Ricardo Fernandes, MD.

Assistant Professor, Department of Oncology, Schulich School of Medicine & Dentistry, Western University. Medical Oncologist and Fellowship Director, Verspeeten Family Cancer Centre, London Health Sciences Centre.

Research Interests / Specializations: Clinical - Breast and Genito-Urinary Cancers. Early phase drug trials, immunotherapy, cancer and biomarkers and microbiome studies.
Barbara Fisher, MD. FRCPC.

Barbara Fisher, MD. FRCPC.

Professor, Department of Oncology, Schulich School of Medicine & Dentistry, Western University. Radiation Oncologist, Verspeeten Family Cancer Centre, London Health Sciences Centre. Scientist, London Health Sciences Research Institute.

Research Interests / Specializations: Radiation Oncology; Biomarkers; GI & Brain cancer; Clinical care; Translational research; Image-guided radiation treatment; Metastasis
Paula Foster, PhD.

Paula Foster, PhD.

Professor, Department of Medical Biophysics, and Oncology, Schulich School of Medicine & Dentistry, Western University. Scientist, Robarts Research Institute. Leader, Cellular & Molecular Imaging Program.

Research Interests / Specializations: Breast cancer; Imaging of occult metastasis; MRI
Jefferson Frisbee, PhD.

Jefferson Frisbee, PhD.

Professor and Chair, Department of Medical Biophysics, Schulich School of Medicine & Dentistry, Western University.

Research Interests / Specializations: Skeletal muscle and cerebral microcirculation, regulation of tissue/organ blood flow, impact of elevated cardiovascular disease risk on microvascular function, vascular disease with chronic stress and depression, microvascular regression with cardiovascular disease, application of chaos theory to microvascular network function.
Stewart Gaede, PhD. MCCPM.

Stewart Gaede, PhD. MCCPM.

Associate Professor, Departments of Oncology, and Medical Biophysics, Schulich School of Medicine & Dentistry, Western University. Chief Medical Physicist, Verspeeten Family Cancer Centre, London Health Sciences Centre. Associate Scientist, London Health Sciences Research Institute.

Research Interests / Specializations: Multi-modal Image-Guided Radiation Therapy, Stereotactic Ablative Radiotherapy, and Respiratory Motion Management
Neil Gelman, PhD.

Neil Gelman, PhD.

Associate Professor, Departments of Medical Biophysics, and Medical Imaging, Schulich School of Medicine & Dentistry, Western University. Scientist, Lawson Research Institute St Joseph's Health Care London.

Research Interests / Specializations: Breast cancer imaging: MRI, hybrid PET-MRI.
Danilo Giffoni, MD. MSc.

Danilo Giffoni, MD. MSc.

Assistant Professor, Department of Oncology, Schulich School of Medicine & Dentistry, Western University. Medical Oncologist, Verspeeten Family Cancer Centre, London Health Sciences Centre. Associate Scientist, London Health Sciences Research Institute. Member, American Association for Cancer Research.

Research Interests / Specializations: Geriatic Oncology, Breast Cancer, including areas of investigating the equivalence between different systemic treatment strategies
Elizabeth Gillies, PhD.

Elizabeth Gillies, PhD.

Professor, Departments of Chemistry, and Chemical and Biochemical Engineering, School of Biomedical Engineering, Western University.

Research Interests / Specializations: Contrast agents; Nanoparticles; Biodegradable polymers for cancer imaging & therapeutic agent delivery
Chris Goodman, MD. FRCPC.

Chris Goodman, MD. FRCPC.

Assistant Professor, Department of Oncology, Schulich School of Medicine & Dentistry, Western University. Radiation Oncologist (head & neck, GI, thoracic), Verspeeten Family Cancer Centre, London Health Sciences Centre.

Research Interests / Specializations: Stereotactic radiation, clinical trials, quality improvement, and innovation in education.
S. M. Mansour Haeryfar, PhD.

S. M. Mansour Haeryfar, PhD.

Professor, Departments of Microbiology & Immunology, Medicine, Oncology, and Surgery, Schulich School of Medicine & Dentistry, Western University. Scientist, Lawson Research Institute St. Joseph's Health Care London. President, Canadian Society for Immunology.

Research Interests / Specializations: Conventional and Innate-like T Cell Responses in Cancer and Infectious Diseases.
Mike Hallett, PhD.

Mike Hallett, PhD.

Western Research Chair, Bioinformatics. Professor, Departments of Biochemistry, and Oncology. Schulich School of Medicine & Dentistry, Western University.

Research Interests / Specializations: Markers of patient benefit from radiation therapy for in situ breast cancer. Causal networks underlying breast cancer subtype differentiation. Systems approaches to the construction of probabilistic biomarker panels.
Caroline Hamm, MD. FRCPC.

Caroline Hamm, MD. FRCPC.

Associate Clinical Professor, Department of Biomedical Sciences, University of Windsor. Associate Professor and Division Lead, Windsor Division, Department of Oncology, Schulich School of Medicine & Dentistry - Windsor Campus. Executive Committee Member, WE-SPARK Health Institute. Chair, Academic and Research Committee, Windsor Regional Hospital. Clinical Research Director, Windsor Cancer Research Group. Medical Oncologist, Cancer Program, Windsor Regional Hospital.

Research Interests / Specializations: Triple negative breast cancer, clinical trials accrual, malignant hematology and melanoma.
Joelle Helou, MD. FRCPC.

Joelle Helou, MD. FRCPC.

Assistant Professor, Department of Oncology, Schulich School of Medicine & Dentistry, Western University. Radiation Oncologist, specializes in breast cancer, GU malignancies, prostate brachytherapy, and extra cranial SBRT, Verspeeten Family Cancer Centre, London Health Sciences Centre.

Research Interests / Specializations: Prostate Brachytherapy, extracranial SBRT, patient reported outcomes with an emphasis on quality of life measurement and health economics.
David J. Hill, D.Phil, FCAHS.

David J. Hill, D.Phil, FCAHS.

Professor, Departments of Medicine, Physiology & Pharmacology and Paediatrics, Schulich School of Medicine & Dentistry, Western University. Lawson Professorship in Diabetes Research. Fellow, Canadian Academy of Health Sciences.

Research Interests / Specializations: Research focuses on the generation of new insulin-producing beta cells in the pancreas as a strategy for the reversal of diabetes.
Jenny Ho, MD. FRCPC.

Jenny Ho, MD. FRCPC.

Assistant Professor, Department of Medicine, Schulich School of Medicine & Dentistry, Western University. Hematologist, Verspeeten Family Cancer Centre, London Health Sciences Centre.

Research Interests / Specializations: Hematology, Myeloid Leukemia
Douglas Hoover, PhD. MCCPM.

Douglas Hoover, PhD. MCCPM.

Assistant Professor, Department of Oncology, Schulich School of Medicine & Dentistry, and Department of Medical Biophysics, Western University. Medical Physicist, Verspeeten Family Cancer Centre, London Health Sciences Centre.

Research Interests / Specializations: Prostate cancer, lung cancer, brachytherapy, functional imaging, machine learning
Christopher Howlett, MD. PhD

Christopher Howlett, MD. PhD

Associate Professor, Department of Pathology and Laboratory Medicine, Schulich School of Medicine & Dentistry, Western University. Pathologist, London Health Sciences Centre. Associate Scientist, Lawson Health Research, St Joseph's Health Care London.

Research Interests / Specializations: Neuroendocrine tumours, lymphoma, molecular pathology.
Cyrus Hsia, MD. FRCPC.

Cyrus Hsia, MD. FRCPC.

Associate Professor, Department of Medicine, Schulich School of Medicine & Laboratory, Western University. Hematologist, Verspeeten Family Cancer Centre, London Health Sciences Centre. Associate Scientist, Lawson Research Institute, St Joseph's Health Care London. Associate Medical Director, Transfusion Medicine Laboratories, London Health Sciences Centre.

Research Interests / Specializations: Hematology and Transfusion Medicine
Pingzhao Hu, PhD.

Pingzhao Hu, PhD.

Associate Professor, Departments of Biochemistry, Computer Science, Epidemiology & Biostatistics, and Oncology, and Statistical and Actuarial Sciences, Schulich School of Medicine & Dentistry, Western University. Associate Scientist, CHRI, and LHRI. Canada Research Chair (CIHR Tier 2).

Research Interests / Specializations: Developing and applying computational and statistical techniques for integrative analysis of big multimodal health data (omics data, imaging data, administrative and electronic medical records) for precision medicine. Building the bridges between artificial intelligence (AI) or machine learning, statistics and multimodal health data (mainly omics data).
Elizabeth Huynh. PhD. DABR.

Elizabeth Huynh. PhD. DABR.

Assistant Professor, Departments of Oncology, and Medical Biophysics. Schulich School of Medicine & Dentistry, Western University. Medical Physicist, Verspeeten Family Cancer Centre, London Health Sciences Centre.

Research Interests / Specializations: My research interests are: image-guided radiation therapy, adaptive radiation therapy, multi-modality imaging and predicting clinical outcomes.
Brant Inman, MD. MS. FRCSC.

Brant Inman, MD. MS. FRCSC.

Chin-Hardie Chair, Urologic Oncology. Professor, Departments of Surgery (Urology), and Oncology, Schulich School of Medicine & Oncology, Western University. Scientist, Cancer Research Laboratory Program, London Health Sciences Research Institute. Urologic Oncologist, Verspeeten Family Cancer Centre, London Health Sciences Centre.

Research Interests / Specializations: Genitourinary cancers (prostate, bladder, kidney, penis, testis), Biomarkers, Translational research, Heat-targeted therapies & nanoparticles, Tumor immunology & immunotherapies, Clinical trials.
Ji-Hyun Jang. MD. FRCPC.

Ji-Hyun Jang. MD. FRCPC.

Assistant Professor, Department of Obstetrics & Gynaecology, Schulich School of Medicine & Dentistry, Western University. Gynecologist Oncologist, Verspeeten Family Cancer Centre, London Health Sciences Centre.

Research Interests / Specializations: Clinical: Gynecologic Oncology. Research Interests: Cancer Survivorship, Bioinformatics, Epidemiology.

Murray Junop, PhD.

Murray Junop, PhD.

Professor, Department of Biochemistry, Western University.

Research Interests / Specializations: Understanding the molecular mechanisms governing repair of various types of DNA damage. Bacterial, yeast and human repair pathways are studied using a variety of genetic and biochemical tools, with the primary emphasis being determination of macromolecular structure using X-ray crystallography.
Richard Kim, MD. FRCPC.

Richard Kim, MD. FRCPC.

Professor, Departments of Biochemistry, and Oncology, Schulich School of Medicine & Dentistry, Western University. Chair and Physician Lead, Division of Clinical Pharmacology & Toxicity. Wolfe Medical Research Chair in Pharmacogenomics. Director, Centre for Clinical & Therapeutics. Scientist, London Health Sciences Research Institute and Children's Health Research Institute.

Research Interests / Specializations: Personalized Medicine, Pharmacogenomics, Drug Metabolism, Drug Transport
Joan Knoll, PhD.

Joan Knoll, PhD.

Emerita Professor Adjunct Professor, Department of Pathology and Laboratory Medicine, Schulich School of Medicine & Dentistry, Western University.

Research Interests / Specializations: Laboratory Medicine; Molecular Pathology; Clinical genetics; Breast cancer; Translational research
Jim Koropatnick, PhD

Jim Koropatnick, PhD

Professor Emeritus, Department of Microbiology & Immunology, Oncology, Physiology & Pharmacology, Pathology. Distinguished Scientist, Verspeeten Family Cancer Centre. Former Director, Cancer Research Laboratory Program. Former Assistant Director, London Health Sciences Research Institute. Former Director, CIHR Strategic Training Initiative in Cancer Research and Technology Transfer (CaRTT).

Research Interests / Specializations: Molecular mechanisms of cancer; Antisense therapeutics; translational research
Sara Kuruvilla, MD. FRCPC.

Sara Kuruvilla, MD. FRCPC.

Associate Professor, Department of Oncology, Schulich School of Medical & Dentistry, Western University. Medical Oncologist, Verspeeten Family Cancer Centre, London Health Sciences Centre. Associate Scientist, London Health Sciences Research Institute. Medical Oncology UGME Program Director.

Research Interests / Specializations: Clinical care, Thoracic oncology; Head and Neck oncology, Clinical Trials, Evaluating factors that could impact survivorship in the treatment of thoracic and head/neck cancers, Medical education, Real world evidence generation.